Menopause Linked to Brain Changes and Increased Alzheimer's Risk

Research indicates that menopause is not just a biological transition marked by hot flashes and mood swings; it may also be a pivotal moment in women's brain health, potentially influencing the risk of Alzheimer's disease later in life. Dr. Lorraine Brinton, Regents Professor at the University of Arizona and director of the Centre for Innovation in Brain Science, provided insights into how decreasing oestrogen levels during menopause may affect brain functions critical for energy production.

Many people assume that the higher prevalence of Alzheimer's disease among women compared to men is simply due to longer life expectancy. However, Dr. Brinton explains that this explanation may be inadequate. 'It’s because the disease can start earlier,' she stated, noting that menopause brings about significant changes in the brain's biological systems.

Oestrogen plays a crucial role in the brain’s ability to metabolise glucose, serving as its primary source of energy. Research suggests that oestrogen can enhance glucose utilisation by 20 to 25 per cent. Following menopause, diminished oestrogen levels can result in approximately a 20 per cent decrease in the brain's ability to convert glucose into energy, prompting what Dr. Brinton terms a ‘starvation response.’ This shift compels the brain to rely more on lipids, or fats, as an alternative energy source.

Dr. Brinton cautions that this metabolic adjustment might extend over many years. As lower oestrogen levels persist, prolonged reliance on alternative energy sources could heighten the risk of Alzheimer's disease in the long run. She clarified that while not every woman undergoing menopause will develop Alzheimer's, it underscores the need for increased awareness of midlife brain health.

In addition to its implications for Alzheimer's risk, symptoms of menopause such as hot flashes may have a neural origin. Dr. Brinton posits that hot flashes result from the brain’s adaptation to fluctuations in energy supply, suggesting that this symptom should be taken seriously by women as it signifies important changes occurring in their brains.

Dr. Brinton also highlights the significance of managing health conditions linked to Alzheimer's risk, stating that research has established a relationship between type 2 diabetes and heightened Alzheimer's risk. Furthermore, medications for diabetes, along with antihypertensive drugs and statins, may help mitigate Alzheimer's risk by supporting the regulation of glucose in the body.

Her team is also investigating a new plant-based formulation known as PhytoSERM, designed to selectively target oestrogen receptor beta without stimulating breast tissue in the same ways as traditional hormone therapies. Given that around 80 per cent of women opt out of conventional menopausal hormone therapy due to concerns over breast cancer, the development of safer interventions is paramount.

Ultimately, Dr. Brinton's findings advocate for the importance of monitoring women's brain health during midlife, especially as menopause may represent a critical window for intervention aimed at preventing neurodegenerative conditions such as Alzheimer’s disease.